We found that GBM patients with high levels of Tctex1 had a significantly shorter overall survival (p = 0.002; log-rank) and progression-free survival (p = 0.028; log-rank) compared to patients with low levels of Tctex1 (Figure 2C,D). Here, DYNLT1 is linked to glioblastoma.